Meyka Pro banner
Noronex Limited

Noronex Limited Fundamental Analysis (ASX: NRX.AX)

NRX.AX●ASX
$0.01
$0.00(0.00%)
Australian Market is Open · 15:51

Noronex Limited Fundamental Analysis (ASX: NRX.AX)

Noronex Limited (ASX: NRX.AX) shows strong financial fundamentals with a PE ratio of 5.88, profit margin of 49.56%, and ROE of 49.80%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE49.80%
Operating Margin25.89%
Cash Position22.15%
PEG Ratio0.02
Current Ratio14.75

Areas of Concern

No major concerns flagged.
We analyze NRX.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 81.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
81.2/100

We analyze NRX.AX's fundamental strength across five key dimensions:

Efficiency Score

Excellent

NRX.AX demonstrates superior asset utilization.

ROA > 10%
35.86%

Valuation Score

Excellent

NRX.AX trades at attractive valuation levels.

PE < 25
5.88
PEG Ratio < 2
0.02

Growth Score

Moderate

NRX.AX shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NRX.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
14.75

Profitability Score

Moderate

NRX.AX maintains healthy but balanced margins.

ROE > 15%
49.80%
Net Margin ≥ 15%
49.56%
Positive Free Cash Flow
No

Key Financial Metrics

Is NRX.AX Expensive or Cheap?

P/E Ratio

NRX.AX trades at 5.88 times earnings. This suggests potential undervaluation.

5.88

PEG Ratio

When adjusting for growth, NRX.AX's PEG of 0.02 indicates potential undervaluation.

0.02

Price to Book

The market values Noronex Limited at 1.98 times its book value. This may indicate undervaluation.

1.98

EV/EBITDA

Enterprise value stands at 14.74 times EBITDA. This signals the market has high growth expectations.

14.74

How Well Does NRX.AX Make Money?

Net Profit Margin

For every $100 in sales, Noronex Limited keeps $49.56 as profit after all expenses.

49.56%

Operating Margin

Core operations generate 25.89 in profit for every $100 in revenue, before interest and taxes.

25.89%

ROE

Management delivers $49.80 in profit for every $100 of shareholder equity.

49.80%

ROA

Noronex Limited generates $35.86 in profit for every $100 in assets, demonstrating efficient asset deployment.

35.86%

Following the Money - Real Cash Generation

Operating Cash Flow

Noronex Limited generates limited operating cash flow of $-6.83M, signaling weaker underlying cash strength.

$-6.83M

Free Cash Flow

Noronex Limited generates weak or negative free cash flow of $-6.83M, restricting financial flexibility.

$-6.83M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

NRX.AX converts -79.53% of its market value into free cash.

-79.53%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

5.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.98

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.20

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

14.75

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.50

vs 25 benchmark

ROA

Return on assets percentage

0.36

vs 25 benchmark

ROCE

Return on capital employed

0.20

vs 25 benchmark

How NRX.AX Stacks Against Its Sector Peers

MetricNRX.AX ValueSector AveragePerformance
P/E Ratio5.8824.44 Better (Cheaper)
ROE49.80%1191.00% Weak
Net Margin49.56%8549.00% Weak
Debt/Equity0.000.64 Strong (Low Leverage)
Current Ratio14.753.02 Strong Liquidity
ROA35.86%88532.00% Weak

NRX.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Noronex Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Commodity, Value

EPS CAGR

N/A

Industry Style: Cyclical, Commodity, Value

FCF CAGR

N/A

Industry Style: Cyclical, Commodity, Value

Fundamental Analysis FAQ